Inovio Pharmaceuticals
INO
#9080
Rank
HK$0.89 B
Marketcap
HK$12.93
Share price
-1.79%
Change (1 day)
-21.12%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.57. In 2024 the company made an earnings per share (EPS) of -HK$30.96 an increase over its 2023 EPS that were of -HK$47.73.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.5%
2024-HK$30.96-35.14%
2023-HK$47.73-56.62%
2022-HK$110.04-19.54%
2021-HK$136.7735.9%
2020-HK$100.64-11.57%
2019-HK$113.8015.24%
2018-HK$98.75-2.78%
2017-HK$101.586.93%
2016-HK$94.99134.88%
2015-HK$40.44-29.51%
2014-HK$57.37-57.34%
2013-HK$134.49146.55%
2012-HK$54.5520.83%
2011-HK$45.15-29.41%
2010-HK$63.96-48.48%
2009-HK$124.1510%
2008-HK$112.8611.11%
2007-HK$101.58-41.3%
2006-HK$173.06-66.91%
2005-HK$522.93110.61%
2004-HK$248.30-61.63%
2003-HK$647.08186.67%
2002-HK$225.73
2001N/A-100%
2000-HK$180.58-63.64%
1999-HK$496.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.69-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.66-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$51.10-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.53-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$9.80-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA